Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | S100B | P04271 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1101313 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL11911281 | 0.91 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL18537896 | 0.91 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL18272407 | 0.89 | CA2 (0.57) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL11686507 | 0.89 | CA2 (0.47) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL8405291 | 0.89 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL8405288 | 0.89 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL19399493 | 0.86 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL13533873 | 0.86 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL11008627 | 0.84 | S100B (0.70) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2470894-B1 | SYNTHETIC MYCOTOXIN ADSORBENTS AND METHODS OF MAKING AND UTILIZING THE SAME | ALLTECH INC (US) | 2021-12-29 | — | — | EP | disclosed |
| US-10472484-B2 | Aflatoxin templates, molecularly imprinted polymers, and methods of making and using the same | ALLTECH, INC. (US) | 2019-11-12 | — | — | US | disclosed |
| US-20180163011-A1 | AFLATOXIN TEMPLATES, MOLECULARLY IMPRINTED POLYMERS, AND METHODS OF MAKING AND USING THE SAME | ALLTECH, INC. (US) | 2018-06-14 | — | — | US | disclosed |
| US-9902830-B2 | Aflatoxin templates, molecularly imprinted polymers, and methods of making and using the same | ALLTECH, INC. (US) | 2018-02-27 | — | — | US | disclosed |
| US-20160347923-A1 | AFLATOXIN TEMPLATES, MOLECULARLY IMPRINTED POLYMERS, AND METHODS OF MAKING AND USING THE SAME | ALLTECH, INC. (US) | 2016-12-01 | — | — | US | disclosed |
| US-20160221983-A1 | AFLATOXIN TEMPLATES, MOLECULARLY IMPRINTED POLYMERS, AND METHODS OF MAKING AND USING THE SAME | ALLTECH, INC. | 2016-08-04 | — | — | US | disclosed |
| US-RE45274-E1 | Synthetic mycotoxin adsorbents and methods of making and utilizing the same | ALLTECH, INC. (US) | 2014-12-02 | — | — | US | disclosed |
| US-8426541-B2 | Synthetic mycotoxin adsorbents and methods of making and utilizing the same | ALLTECH, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20120214897-A1 | SYNTHETIC MYCOTOXIN ADSORBENTS AND METHODS OF MAKING AND UTILIZING THE SAME | ALLTECH, INC. (US) | 2012-08-23 | — | — | US | disclosed |
| US-8153737-B2 | Synthetic mycotoxin adsorbents and methods of making and utilizing the same | ALLTECH, INC. (US) | 2012-04-10 | — | — | US | disclosed |
| US-20110054132-A1 | SYNTHETIC MYCOTOXIN ADSORBENTS AND METHODS OF MAKING AND UTILIZING THE SAME | ALLTECH, INC. (US) | 2011-03-03 | — | — | US | disclosed |
| US-20020001821-A1 | Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof | MOSBACH KLAUS (SE) | 2002-01-03 | — | — | US | disclosed |
| US-6127154-A | Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof | KLAUS MOSBACH, CENTER FOR CHEMISTRY AND CHEMICAL ENGINEERING, PURE AND APPLIED BIOCHEMISTRY (SE) | 2000-10-03 | — | — | US | disclosed |
| US-5994110-A | Methods for direct synthesis of compounds having complementary structure to a desired molecular entity and use thereof | KLAUS MOSBACH, CENTER FOR CHEMISTRY AND CHEMICAL ENGINEERING, PURE AND APPLIED BIOCHEMISTRY (SE) | 1999-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180163011-A1 | AFLATOXIN TEMPLATES, MOLECULARLY IMPRINTED POLYMERS, AND METHODS OF MAKING AND USING THE SAME | AKR7A2, IGF2R, CD68 | ALDH1A1 1736/4885MEN1 851/4885KMT2A 2679/4885 |
| US-10472484-B2 | Aflatoxin templates, molecularly imprinted polymers, and methods of making and using the same | AKR7A2, IGF2R, CD68 | ALDH1A1 1736/4885MEN1 851/4885KMT2A 2679/4885 |
| US-20160221983-A1 | AFLATOXIN TEMPLATES, MOLECULARLY IMPRINTED POLYMERS, AND METHODS OF MAKING AND USING THE SAME | AKR7A2, IGF2R, CD68 | ALDH1A1 1736/4885MEN1 851/4885KMT2A 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.